A Critical Assessment of the United States Implementation of the OECD Guidelines for Multinational Enterprises

As Western corporations continue to expand internationally in search of natural resources and greater economies of scale, they increasingly find themselves operating amidst the political unrest and social conflict that afflicts many developing nations. In such contexts, multinational enterprises often turn a blind eye to human rights abuses, and in the worst cases, become active participants. As a result, many have called for a global system of corporate governance. This Note focuses on the OECD’s framework for influencing corporate behavior internationally: the “OECD Guidelines for Multinational Enterprises.” After explaining the mechanics of the Guidelines, this Note provides a critical analysis of the United States’ implementation by comparing U.S. methods with those of two other adherent states—the Netherlands and France. Ultimately, the Note concludes that U.S. practices leave much room for improvement and offers suggestions for a more robust imple-mentation of the Guidelines

Serum and macular responses to antioxidant supplementation verus a carotenoid-rich dietary intervention in the elderly.

Journal ArticleThe aim of this study was to observe responses of serum antioxidants, oxidative stress biomarkers, and macular carotenoid pigments to antioxidant supplements or dietary intervention in a single-masked, randomized, pilot clinical study of elderly subjects receiving antioxidant supplements or a dietary intervention. Methods: From a pool of ninety-eight community volunteers, forty-eight male and female subjects (age 65-85) with the lowest baseline serum lutein + zeaxanthin levels were selected and randomly assigned to receive for 12 weeks one of two different antioxidant supplements or a diet rich in fruits and vegetables containing approximately matched levels of four classes of carotenoids: carotenes, the xanthophylls lutein and zeaxanthin, and lycopene. Forty-six completed the study. Both supplements and diet also were rich in vitamins C and E. Outcome measures were changes from baseline: 1) in serum levels of antioxidant micronutrients (vitamins C and E, lutein, zeaxanthin, and carotene); 2) in levels of indicators of oxidative stress: serum lipid peroxides (LPO) and urinary 8-hydroxydeoxyguanosine (8-OHdG); and 3) macular pigment, measured by heterochromatic flicker photometry. Results: Interventions to promote eye health by either diet or supplementation showed consistent serum responses, with substantial improvements within twelve weeks. Serum lutein and vitamin C increased for all groups (p< 0.05), and lipid peroxides decreased for all subjects (p< 0.05); nonetheless, mean macular pigment did not increase significantly during the designated timeframe. Conclusion: Supplementation of elderly individuals potentially at risk for AMD with two different types of antioxidant formulations exhibited positive serum responses similar to a dietary intervention containing approximately comparable levels of carotenoids. This pilot study indicates that the ocular supplements tested in this study elicited responses in serum parameters similar to daily consumption of four servings of carotenoid-rich fruits and vegetables. The study also provides useful criteria for the design of larger-scale and longer-term studies of antioxidant supplementation in an elderly population potentially at risk for AMID

Efficacy of Medical Operations and Layout Planning Onboard Nontraditional US Navy Vessels at High Seas

The article of record as published may be found at http://dx.doi.org/10.1093/milmed/usz227Introduction: Attempting to expedite delivery of care to wounded war fighters, this study aimed to quantify the ability of medical and surgical teams to perform lifesaving damage control and resuscitation procedures aboard nontraditional US Navy Vessels on high seas. Specifically, it looked at the ability of the teams to perform procedures in shipboard operating and emergency rooms by analyzing motion of personnel during the procedures. Methods: One hundred and twelve damage control and resuscitation procedures were performed during a voyage of the US Naval Ship Brunswick in transit from Norfolk, Virginia, to San Diego, California. The ability of personnel to perform these procedures was quantified by the use of motion link analysis designed to track the movement of each participant as they completed their assigned tasks. Results: The link analysis showed no significant change in the number of movements of participants from the beginning to the end of the study. However, there was a learning effect observed during the study, with teams completing tasks faster at the end of the study than at the beginning. Conclusion: This shows that the working conditions aboard the US Naval Ship Brunswick were satisfactory for the assigned tasks, indicating that these medical operations may be feasible aboard nontraditional US Navy vessels.This specific study was a part of a major three-phase investigation entitled �Effect of High Deck Accelerations on Surgical Tasks� funded by the following organizations for each phase: Phase I�Office of Naval Research, Phase II�Office of the Chief of Naval Operations (OPNAV) N81, and Phase III�Advanced Medical Development and OPNAV N81.This specific study was a part of a major three-phase investigation entitled �Effect of High Deck Accelerations on Surgical Tasks� funded by the following organizations for each phase: Phase I�Office of Naval Research, Phase II�Office of the Chief of Naval Operations (OPNAV) N81, and Phase III�Advanced Medical Development and OPNAV N81

Assessing Surgical Task Load and Performance: A Comparison of Simulation and Maritime Operation

The article of record as published may be found at http://dx.doi.org/10.1093/milmed/usz297This study examined the effects of simulated and actual vessel motion at high seas on task load and surgical performance. Methods: This project was performed in phases. Phase I was a feasibility study. Phase II utilized a motion base simulator to replicate vessel motion. Phase III was conducted aboard the U.S. Naval Ship Brunswick. After performing surgical tasks on a surgical simulation mannequin, participants completed the Surgical Task Load Index (TLX) designed to collect workload data. Simulated surgeries were evaluated by subject matter experts. Results: TLX scores were higher in Phase III than Phase II, particularly at higher sea states. Surgical performance was not significantly different between Phase II (84%) and Phase III (89%). Simulated motions were comparable in both phases. Conclusions: Simulated motion was not associated with a significant difference in surgical performance or deck motion, suggesting that this simulator replicates the conditions experienced during surgery at sea on the U.S. Naval Ship Brunswick. However, Surgical TLX scores were dramatically different between the two phases, suggesting increased workload at sea, which may be the result of time at sea, the stress of travel, or other factors. Surgical performance was not affected by sea state in either phase.Bureau of Medicine USN; OPNAV N-81 Assessments Division, Medical Analysis Branch; Navy Advanced Medical Development; Naval Surface Warfare Center, PC.Phase I of this study was sponsored by the Office of Naval Research. Phase II was sponsored by the Office of the Chief of Naval Operations (OPNAV) N-81 Assessments Division, Medical Analysis Branch (N813). Phase III was sponsored by the OPNAV N-81 (N813) and Navy Advanced Medical Development (AMD).Bureau of Medicine USN; OPNAV N-81 Assessments Division, Medical Analysis Branch; Navy Advanced Medical Development; Naval Surface Warfare Center, PC.Phase I of this study was sponsored by the Office of Naval Research. Phase II was sponsored by the Office of the Chief of Naval Operations (OPNAV) N-81 Assessments Division, Medical Analysis Branch (N813). Phase III was sponsored by the OPNAV N-81 (N813) and Navy Advanced Medical Development (AMD)

A Scenario Based Methodology for the Selection of Non-Lethal Weapons

A paper submitted to Non-Lethal Defense III, Johns Hopkins Applied Physics Laboratory, Laurel, Maryland, by the Naval Postgraduate School's Non-Lethal Weapons System Engineering Study Team, February 1998.The allocation of finite resources to develop non-lethal weapons for deployment as effective military assets is a difficult task considering that there exists a myriad of potentially promising technologies. Each proposed weapon has operational, logistical, and developmental advantages and disadvantages,which often do not appear self-consistent. Attempts to invent a common figure-of-merit often fail because it is difficult to avoid subjective criteria and evaluation. Ideally, an objective, consistent weapons selection methodology is required. We have developed a scenario based requirements methodology that allows us to highlight inter-scenario commonalties among the weapons considered. We have evaluated some thirty different anti-personnel and anti-material weapons considering over a dozen scenario based requirements including such criteria as effective range, weather susceptibility, cost, logistics and training

Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration.

BACKGROUND: It has been proposed that antioxidants may prevent cellular damage in the retina by reacting with free radicals that are produced in the process of light absorption. OBJECTIVES: The objective of this review was to assess the effects of antioxidant vitamin or mineral supplementation, or both, on the progression of age-related macular degeneration (AMD). SEARCH STRATEGY: We searched the Cochrane Central Register of Controlled Trials (CENTRAL) in The Cochrane Library (2005, Issue 4); MEDLINE (1966 to January 2006); SIGLE (1980 to March 2005); EMBASE (1980 to January 2005); NRR (2005, Issue 4); AMED (1985 to January 2006); and PubMed (24 January 2006 covering last 60 days), reference lists of identified reports and the Science Citation Index. We contacted investigators and experts in the field for details of unpublished studies. SELECTION CRITERIA: We included randomised trials comparing antioxidant vitamin or mineral supplemention (alone or in combination) to a control intervention in people with AMD. DATA COLLECTION AND ANALYSIS: The author extracted data and assessed trial quality. Where appropriate, data were pooled using a random-effects model unless three or fewer trials were available in which case a fixed-effects model was used. MAIN RESULTS: Eight trials were included in this review. The majority of people were randomised in one trial (AREDS in the USA) that found a beneficial effect of antioxidant (beta-carotene, vitamin C and vitamin E) and zinc supplementation on progression to advanced AMD (adjusted odds ratio 0.68, 99% confidence interval 0.49 to 0.93). People taking supplements were less likely to lose 15 or more letters of visual acuity (adjusted odds ratio 0.77, 99% confidence interval 0.58 to 1.03). Hospitalisation for genito-urinary problems was more common in people taking zinc and yellowing of skin was more common in people taking antioxidants. The other trials were, in general, small and the results were inconsistent. AUTHORS' CONCLUSIONS: The evidence as to the effectiveness of antioxidant vitamin and mineral supplementation in halting the progression of AMD comes mainly from one large trial in the USA. The generalisability of these findings to other populations with different nutritional status is not known. Further large, well-conducted randomised controlled trials in other populations are required. Long-term harm from supplementation cannot be ruled out. Beta-carotene has been found to increase the risk of lung cancer in smokers; vitamin E has been associated with an increased risk of heart failure in people with vascular disease or diabetes

Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration.

BACKGROUND: It has been proposed that antioxidants may prevent cellular damage in the retina by reacting with free radicals that are produced in the process of light absorption. Higher dietary levels of antioxidant vitamins and minerals may reduce the risk of progression of age-related macular degeneration (AMD). OBJECTIVES: The objective of this review was to assess the effects of antioxidant vitamin or mineral supplementation on the progression of AMD in people with AMD. SEARCH METHODS: We searched CENTRAL (which contains the Cochrane Eyes and Vision Group Trials Register) (The Cochrane Library 2012, Issue 8), Ovid MEDLINE, Ovid MEDLINE In-Process and Other Non-Indexed Citations, Ovid MEDLINE Daily, Ovid OLDMEDLINE (January 1946 to August 2012), EMBASE (January 1980 to August 2012), Allied and Complementary Medicine Database (AMED) (January 1985 to August 2012), OpenGrey (System for Information on Grey Literature in Europe) (www.opengrey.eu/), the metaRegister of Controlled Trials (mRCT) (www.controlled-trials.com), ClinicalTrials.gov (www.clinicaltrials.gov) and the WHO International Clinical Trials Registry Platform (ICTRP) (www.who.int/ictrp/search/en). We did not use any date or language restrictions in the electronic searches for trials. We last searched the electronic databases on 20 August 2012. We searched the reference lists of identified reports and the Science Citation Index. We contacted investigators and experts in the field for details of unpublished studies. We also searched for systematic reviews of harms of vitamin supplements. SELECTION CRITERIA: We included randomised trials comparing antioxidant vitamin or mineral supplementation (alone or in combination) to placebo or no intervention in people with AMD. DATA COLLECTION AND ANALYSIS: Two authors assessed risk of bias and extracted data from the included trials. Where appropriate, we pooled data using a random-effects model unless three or fewer trials were available in which case we used a fixed-effect model. MAIN RESULTS: Thirteen trials (6150 participants) were included in this review. Over half the participants (3640) were randomised in one trial (AREDS in the USA), which found a beneficial effect of antioxidant (beta-carotene, vitamin C and vitamin E) and zinc supplementation on progression to advanced AMD (adjusted odds ratio (OR) 0.68, 95% confidence interval (CI) 0.53 to 0.87) over an average of 6.3 years. People taking supplements were less likely to lose 15 or more letters of visual acuity (adjusted OR 0.77, 95% CI 0.62 to 0.96). The other trials, in general, had shorter follow-up (less than two years). No evidence for an effect of supplementation was seen in these smaller trials of shorter duration. Overall we considered the strength of the evidence to be moderate. We did not consider included trials, in general, to be at risk of bias, although we found it difficult to assess reporting biases. The main reason for downgrading the strength of the evidence was because, for several analyses, only one trial was included and therefore consistency of the findings could not be assessed. The included trials reported the following adverse effects: hospitalisation for genito-urinary problems was more common in people taking zinc and yellowing of skin was more common in people taking antioxidants. Systematic searching of the literature identified other potential harms of vitamin supplementation, in particular an increased risk of lung cancer in smokers associated with beta-carotene supplements, but we were unable to identify a good systematic review of the evidence for harms of nutritional supplementation. AUTHORS' CONCLUSIONS: People with AMD may experience delay in progression of the disease with antioxidant vitamin and mineral supplementation. This finding is drawn from one large trial conducted in a relatively well-nourished American population. The generalisability of these findings to other populations is not known. Although generally regarded as safe, vitamin supplements may have harmful effects. A systematic review of the evidence on harms of vitamin supplements is needed

Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration

Background: It has been proposed that antioxidants may prevent cellular damage in the retina by reacting with free radicals that are produced in the process of light absorption. Higher dietary levels of antioxidant vitamins and minerals may reduce the risk of progression of age-related macular degeneration (AMD). Objectives: The objective of this review was to assess the effects of antioxidant vitamin or mineral supplementation on the progression of AMD in people with AMD. Search methods: We searched CENTRAL (2017, Issue 2), MEDLINE Ovid (1946 to March 2017), Embase Ovid (1947 to March 2017), AMED (1985 to March 2017), OpenGrey (System for Information on Grey Literature in Europe, the ISRCTN registry (www.isrctn.com/editAdvancedSearch), ClinicalTrials.gov (www.clinicaltrials.gov) and the WHO International Clinical Trials Registry Platform (ICTRP) (www.who.int/ictrp/search/en). We did not use any date or language restrictions in the electronic searches for trials. We last searched the electronic databases on 29 March 2017. Selection criteria: We included randomised controlled trials (RCTs) that compared antioxidant vitamin or mineral supplementation (alone or in combination) to placebo or no intervention, in people with AMD. Data collection and analysis: Both review authors independently assessed risk of bias in the included studies and extracted data. One author entered data into RevMan 5; the other author checked the data entry. We graded the certainty of the evidence using GRADE. Main results: We included 19 studies conducted in USA, Europe, China, and Australia. We judged the trials that contributed data to the review to be at low or unclear risk of bias. Nine studies compared multivitamins with placebo (7 studies) or no treatment (2 studies) in people with early and moderate AMD. The duration of supplementation and follow-up ranged from nine months to six years; one trial followed up beyond two years. Most evidence came from the Age-Related Eye Disease Study (AREDS) in the USA. People taking antioxidant vitamins were less likely to progress to late AMD (odds ratio (OR) 0.72, 95% confidence interval (CI) 0.58 to 0.90; 2445 participants; 3 RCTs; moderate-certainty evidence). In people with very early signs of AMD, who are at low risk of progression, this would mean that there would be approximately 4 fewer cases of progression to late AMD for every 1000 people taking vitamins (1 fewer to 6 fewer cases). In people at high risk of progression (i.e. people with moderate AMD) this would correspond to approximately 8 fewer cases of progression for every 100 people taking vitamins (3 fewer to 13 fewer). In one study of 1206 people, there was a lower risk of progression for both neovascular AMD (OR 0.62, 95% CI 0.47 to 0.82; moderate-certainty evidence) and geographic atrophy (OR 0.75, 95% CI 0.51 to 1.10; moderate-certainty evidence) and a lower risk of losing 3 or more lines of visual acuity (OR 0.77, 95% CI 0.62 to 0.96; 1791 participants; moderate-certainty evidence). Low-certainty evidence from one study of 110 people suggested higher quality of life scores (National Eye Institute Visual Function Questionnaire) in treated compared with the non-treated people after 24 months (mean difference (MD) 12.30, 95% CI 4.24 to 20.36). Six studies compared lutein (with or without zeaxanthin) with placebo. The duration of supplementation and follow-up ranged from six months to five years. Most evidence came from the AREDS2 study in the USA. People taking lutein or zeaxanthin may have similar or slightly reduced risk of progression to late AMD (RR 0.94, 95% CI 0.87 to 1.01; 6891 eyes; low-certainty evidence), neovascular AMD (RR 0.92, 95% CI 0.84 to 1.02; 6891 eyes; low-certainty evidence), and geographic atrophy (RR 0.92, 95% CI 0.80 to 1.05; 6891 eyes; low-certainty evidence). A similar risk of progression to visual loss of 15 or more letters was seen in the lutein and control groups (RR 0.98, 95% CI 0.91 to 1.05; 6656 eyes; low-certainty evidence). Quality of life (measured with Visual Function Questionnaire) was similar between groups in one study of 108 participants (MD 1.48, 95% -5.53 to 8.49, moderate-certainty evidence). One study, conducted in Australia, compared vitamin E with placebo. This study randomised 1204 people to vitamin E or placebo, and followed up for four years. Participants were enrolled from the general population; 19% had AMD. The number of late AMD events was low (N = 7) and the estimate of effect was uncertain (RR 1.36, 95% CI 0.31 to 6.05, very low-certainty evidence). There were no data on neovascular AMD or geographic atrophy.There was no evidence of any effect of treatment on visual loss (RR 1.04, 95% CI 0.74 to 1.47, low-certainty evidence). There were no data on quality of life. Five studies compared zinc with placebo. The duration of supplementation and follow-up ranged from six months to seven years. People taking zinc supplements may be less likely to progress to late AMD (OR 0.83, 95% CI 0.70 to 0.98; 3790 participants; 3 RCTs; low-certainty evidence), neovascular AMD (OR 0.76, 95% CI 0.62 to 0.93; 2442 participants; 1 RCT; moderate-certainty evidence), geographic atrophy (OR 0.84, 95% CI 0.64 to 1.10; 2442 participants; 1 RCT; moderate-certainty evidence), or visual loss (OR 0.87, 95% CI 0.75 to 1.00; 3791 participants; 2 RCTs; moderate-certainty evidence). There were no data reported on quality of life. Very low-certainty evidence was available on adverse effects because the included studies were underpowered and adverse effects inconsistently reported. Authors' conclusions: People with AMD may experience some delay in progression of the disease with multivitamin antioxidant vitamin and mineral supplementation. This finding was largely drawn from one large trial, conducted in a relatively well-nourished American population. We do not know the generalisability of these findings to other populations. Although generally regarded as safe, vitamin supplements may have harmful effects. A systematic review of the evidence on harms of vitamin supplements is needed. Supplements containing lutein and zeaxanthin are heavily marketed for people with age-related macular degeneration but our review shows they may have little or no effect on the progression of AMD

Spin and magnetism: two transfer matriz formulations of a classical Heisenberg Ring in a Magnetic Field

Nanometer scale fabrication and experimental investigations into the magnetic properties of mesoscopic molecular clusters have specifically addressed the need for theoretical models to as certain thermodynamic properties. Technological applications germane to these inquiries potentially include minimum scale ferromagnetic data storage and quantum computing. The one- dimensional nearest neighbor Heisenberg spin system accurately models the energy exchange of certain planar rings of magnetic ions. Seeking the partition function from which a host of thermodynamic quantities may be obtained, this thesis contrasts two transfer matrix formulations of a classical Heisenberg ring in a magnetic field. Following a discussion of the transfer matrix technique in an Ising model and a review of material magnetic characteristics, a Heisenberg Hamiltonian development establishes the salient integral eigenvalue equation. The 1975 technique of Blume et al turns the integral equation into a matrix eigenvalue equation using Gaussian numerical integration. This thesis alternatively proposes an exactly formulated matrix eigenvalue equation, deriving the matrix elements by expanding the eigenvectors in a basis of the spherical harmonics. Representing the energy coupling of the ring to a magnetic field with symmetric or asymmetric transfer operators develops pragmatically distinctive matrix elements; the asymmetric yielding a simpler expression. Complete evaluation will require follow-on numerical analysishttp://www.archive.org/details/spinmagnetismtwo00franCommander, United States NavyApproved for public release; distribution is unlimited